BioSpace News Archive

Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced that it will issue financial results for the fourth quarter and fiscal year 2022 on Thursday, March 2, 2023, at 6:30 a.m.

MannKind Corporation will release its 2022 fourth quarter and full year financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM on Thursday, February 23, 2023.

BIOLASE, Inc., the global leader in dental lasers, announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023.

Chiesi Global Rare Diseases announced that the U.S. Food and Drug Administration has approved Lamzede® for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients.

Daiichi Sankyo Co., Ltd. announced that the U.S. Patent and Trademark Office granted its request to re-institute post-grant review of the patentability of certain claims of Seagen’s U.S. patent 10,808,039.

Valneva SE a specialty vaccine company, reported its revenue and cash balance for the full year 2022 and provided first full year 2023 sales guidance.

AQILION AB announced an exclusive license and strategic research collaboration with Merck to discover, develop and commercialize small molecule inhibitors of the transforming growth factor-β-activated kinase 1 protein.

Valo Therapeutics Oy announces it has been granted European patents EP3768305 and EP3768830, issued by the European Patent Office on 7 February 2023.

Tubulis announced the appointment of Björn Hock, PhD, as Chief Development Officer to further strengthen its leadership team with a seasoned drug development expert.

Syneos Health, a leading fully integrated biopharmaceutical solutions organization, reported financial results for the three months and year ended December 31, 2022.